Ramachandran Meenakshisundaram

Ramachandran Meenakshisundaram

Auto-generated profile, based on publicly available information

Ramachandran Meenakshisundaram

Department of Emergency & Critical Care, Manian Medical Centre, Erode, India

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2009 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
RMRamachandran Meenakshisundaram
Ramachandran Meenakshisundaram
SSShah Sweni
Shah Sweni
PTPonniah Thirumalaikolundusubramanian
Ponniah Thirumalaikolundusubramanian
Background: Snake and insect venoms have been demonstrated to have beneficial effects in the treatment of certain diseases including drug resistant human immunodeficiency virus (HIV) infection. We evaluated and hypothesized the probable mechanisms of venoms against HIV. Methods: Previous literatures published over a period of 30 years (1979-2009) were searched using the key words snake venom, insect venom, mechanisms and HIV. Mechanisms were identified and discussed. Results & Conclusion: With reference to mechanisms of action, properties and components of snake venom such as sequence homology and enzymes (protease or L- amino acid oxidase) may have an effect on membrane protein and/or act against HIV at multiple levels or cells carrying HIV virus resulting in enhanced effect of anti-retroviral therapy (ART). This may cause a decrease in viral load and improvement in clinical as well as immunological status. Insect venom and human Phospholipase A2 (PLA2) have potential anti-viral activity through inhibition of virion entry into the cells. However, all these require further evaluation in order to establish its role against HIV as an independent one or as a supplement.

1 October 2020 in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Verified
Journal Article
Open access
RMRamachandran Meenakshisundaram
Ramachandran Meenakshisundaram
SSSubramanian Senthilkumaran
Subramanian Senthilkumaran
PTPonniah Thirumalaikolundusubramanian
Ponniah Thirumalaikolundusubramanian
MJMelvin Joy
Melvin Joy
NJNarendra Nath Jena
Narendra Nath Jena
VCV.P. Chandrasekaran
V.P. Chandrasekaran
There has been a reduction in the reported cases of acute myocardial infarction (MI) across the globe during the outbreak of coronavirus disease 2019 (COVID-19) (severe acute respiratory distress syndrome coronavirus 2). An attempt was made to find out the number of acute MI cases treated during the COVID-19 lockdown period (April 2020) and highlight the possible reasons for the changes in the occurrence. A multicentric retrospective observational study was performed to collect the selected data from 12 private hospitals distributed in 4 cities—Madurai, Trichy (Thiruchirapalli), Erode, and Salem—of the Tamil Nadu state in southern India. There was a significant (P<.001) reduction in ST-segment elevation MI (STEMI), non-STEMI (NSTEMI), and total (STEMI and NSTEMI together) cases during the lockdown period (April 1 to 30, 2020) as compared with no-lockdown periods such as January and February 2020 and April 2019 and April 2018 in all cities, whereas the reduction was not significant for NSTEMI in Trichy when data for the lockdown period was compared with those for January and February 2020. Overall, there is a reduction in acute MI cases, which may be due to alterations in modifiable risk factors during the COVID-19 lockdown period. Hence, implementation of public education and polices on controlling modifiable risk factors is likely to pay dividends.

1 October 2020 in Medical Hypotheses
Verified
Journal Article
Closed access
RMRamachandran Meenakshisundaram
Ramachandran Meenakshisundaram
SSSubramanian Senthilkumaran
Subramanian Senthilkumaran
PTPonniah Thirumalaikolundusubramanian
Ponniah Thirumalaikolundusubramanian

1 May 2019 in Mayo Clinic Proceedings
Verified
Journal Article
Open access
PDF file
SSSubramanian Senthilkumaran
Subramanian Senthilkumaran
RMRamachandran Meenakshisundaram
Ramachandran Meenakshisundaram
WOWedatallah Osman
Wedatallah Osman
PTPonniah Thirumalaikolundusubramanian
Ponniah Thirumalaikolundusubramanian
The article on acute myocardial infarction (AMI) during pregnancy and the puerperium by Smilowitz et al1 x 1 Smilowitz, N.R., Gupta, N., Guo, Y. et al. Acute myocardial infarction during pregnancy and the puerperium in the United States. Mayo Clin Proc. 2018; 93: 1404–1414 Abstract | Full Text | Full Text PDF | PubMed | Scopus (2) | Google Scholar See all References is informative and useful for physicians and obstetricians to consider this rare fatal entity. Some of our clinical experiences, and the challenges faced from southern India, are shared here.

15 July 2020 in Clinical and Experimental Pediatrics
Verified
Journal Article
Open access
PDF file
SSSweni Shah
Sweni Shah
RMRamachandran Meenakshisundaram
Ramachandran Meenakshisundaram
SSSubramanian Senthilkumaran
Subramanian Senthilkumaran
PTPonniah Thirumalaikolundusubramanian
Ponniah Thirumalaikolundusubramanian

1 September 2020 in The Journal of Emergency Medicine
Verified
Journal Article
Open access
Subramanian SenthilkumaranSubramanian Senthilkumaran
Subramanian Senthilkumaran
SAS.V. Arathisenthil
S.V. Arathisenthil
RMRamachandran Meenakshisundaram
Ramachandran Meenakshisundaram
PTPonniah Thirumalaikolundusubramanian
Ponniah Thirumalaikolundusubramanian
VCV.P. Chandrasekaran
V.P. Chandrasekaran